Try our beta test site

Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH (NASH)

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01672879
First received: August 22, 2012
Last updated: February 23, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 3, 2017
  Primary Completion Date: July 28, 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: February 23, 2017